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Abstract
Background: Multi Drug Resistant Tuberculosis (MDR TB) is a threat to global tuberculosis control. A significant fitness cost
has been associated with DR strains from specific lineages. Evaluation of the influence of the competing drug susceptible
strains on fitness of drug resistant strains may have an important bearing on understanding the spread of MDR TB. The aim
of this study was to evaluate the fitness of MDR TB strains, from a TB endemic region of western India: Mumbai, belonging
to 3 predominant lineages namely CAS, Beijing and MANU in the presence of drug susceptible strains from the same
lineages.
Methodology: Drug susceptible strains from a single lineage were mixed with drug resistant strain, bearing particular non
synonymous mutation (rpoB D516V; inhA, A16G; katG, S315T1/T2) from the same or different lineages. Fitness of
M.tuberculosis (M.tb) strains was evaluated using the difference in growth rates obtained by using the CFU assay system.
Conclusion/Significance: While MANU were most fit amongst the drug susceptible strains of the 3 lineages, only Beijing MDR
strains were found to grow in the presence of any of the competing drug susceptible strains. A disproportionate increase in
Beijing MDR could be an alarm for an impending epidemic in this locale. In addition to particular non synonymous
substitutions, the competing strains in an environment may impact the fitness of circulating drug resistant strains.
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Introduction
Fitness, virulence and infectiousness of a pathogen are defined
as its ability to cause and transmit a disease. A strain’s fitness is also
a reflection of the robustness of its biological system that continues
to function, survive and/or reproduce despite accumulating
mutations, environmental change and internal noise [1]. This
robustness/fitness in M.tb has been assessed and translated using
in-vitro competition assays measuring the ‘fitness’ of the strains.
There are several factors that are known to affect the fitness of
circulating strains: drug pressures, environmental changes, geno-
type of the strain and the stress induced by the competing strains.
All these factors either independently or together put the bacterial
population under fluctuating selection pressure [2]. Strain diversity
and mutations ensure that some bacteria survive the adverse
conditions and become the predominant population. Such
survivors tend to have a greater fitness index and thus a greater
ability to transmit the disease [3]. These survivors also pose a
threat to disease control as the common measures to tackle the
disease do not hold true for them.
An example of greater fitness is the efficacy of Beijing strains
which acquire drug resistance, evade BCG vaccination and also
disseminate more efficiently [4–5]. Additionally drug resistant M.
tb displays diverse fitness, wherein some strains were more fit than
the drug susceptible wild type strains [6]. The enhanced fitness of
these circulating drug resistant strains in a community could give
rise to MDR TB epidemics [7]. This mechanism of enhanced
fitness of drug resistant strains has been explained earlier [6,8]
All studies conducted till date have been focused either on
standard laboratory generated mutant strains or particular
lineages such as the W/Beijing [9] due to its association with
disease severity, MDR and large epidemic outbreaks. There is
currently a lack of information on the relative fitness of strains
originating from TB endemic areas such as metropolitan Mumbai.
Fitness of strains may be affected by high levels of drug resistance
[10–12], strain heterogeneity along with a significant level of
clustering [13–15] and host variability. Fitness studies in endemic
regions will not only help in predicting the success of tuberculosis
control programs but also in predicting ‘strain replacement’ and
thus the efficacy of new vaccine candidates [16]. All these factors
along with other environmental factors allow several strain types to
co-exist but only a select few to predominate.
There are several assays to estimate fitness of strains. However it
is debatable as to which assay best simulates in vivo conditions. In
competition experiments, it is usually assumed that the competing
strains do not affect each other and that they compete only by
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nutrients. Thus we have chosen growth rate as a measure of
relative fitness for competing strains in vitro [17].
The aim of the present study therefore was to measure and
compare growth of drug resistant and susceptible M.tb strains of
predominant genotypes {MANU, CAS & Beijing (23, 9 & 4% of
total strains respectively)} in the TB endemic region of Mumbai in
Western India, and to determine whether the genotype of the
competing drug susceptible strain has an impact on the fitness of
drug resistant strains from the same or different genotypes. It may
be recapitulated that MANU was the predominant lineage and
Beijing was significantly associated with MDR [14].
Materials and Methods
Ethics Statement
Clearance for this study was obtained from the Foundation for
Medical Research (FMR) Institutional Ethics Committee
(20.07.2001/01).
Study population
A total of 723 isolates were collected from patients reporting to
RNTCP (Revised National Tuberculosis Control program) health
posts in 4 municipal wards of Mumbai. Of these 24% of previously
untreated, new cases and 41% of first time treatment failures (new cases
that have remained sputum positive at theend of antiTB therapy) were
reportedly diagnosed with MDR TB [10]. The population thus
represents an endemic region with high burden of MDR TB.
Strain Selection
Strains isolated from new TB patients (n=646) were subjected
to molecular fingerprinting through spoligotyping and Drug
Susceptibility Testing (DST) by the BACTEC MGIT 960 method
for the four first line anti tuberculosis drugs viz, Isoniazid (H),
Rifampicin (R), Ethambutol (E) and Pyrazinamide (Z) [10].
Spoligotyping identified 4 major clusters in the region, which
were identified using Spoldb4 as the following lineages namely:
MANU (23%), CAS (9%), Beijing (4%), and EAI-5 (4%) [14]. Of
these CAS, Beijing and MANU strains resistant to HR+E/Z and
2/3, drug susceptible isolates from each of the 3 lineages with
particular non synonymous substitutions in the rpoB, inhA and katG
locus were chosen for the intra and inter lineage strain competition
assays. The laboratory standard strain H37Rv was used as a drug
susceptible control.
Genotypic Study
To ensure that mutations in rpoB, inhA, and katG genes did not
influence the fitness of drug resistant strains, 3 drug resistant
strains were chosen with identical mutations in these regions.
These were the most frequently observed mutations in these loci
which were identified using a commercial line probe assay
(GenoType MTBDR plus, Hain Life sciences) [18]. The details
of the same have been presented in Table 1.
In our study, all the drug resistant and susceptible strains bore
the same drug susceptibility profile when compared using
Phenotypic (BACTEC MGIT TB 960) and genotypic (Genotype
MTBDR plus, Hains life sciences) methods (data not shown).
Strain Cultivation and growth
The strains were taken from Lowenstein-Jensen medium (Hi-
Media, India) and inoculated into Middlebrook 7H9 (MB7H9)
(Becton Dickinson, USA) supplemented with ADC (Alanine
Dextrose and Catalse) (Becton Dickinson, USA), 0.5% glycerol
broth for 3–4 weeks at 37uC. The cultures were maintained on a
Table 1. Characteristics of 12 strains from endemic region of Western India: Mumbai.
Strain ID Resistance to Cluster- Spoligotyping Mutation in rpo b gene
Mutation in kat G
gene
Mutation in inh A
gene
H37Rv Susceptible - Wild type Wild type Wild type
Cs1 Susceptible CAS Wild type Wild type Wild type
Cs2
Cs3
C-MDR HERZ D516V S315T1 A16G
S315T2
Bs1 Susceptible Beijing Wild type Wild type Wild type
Bs2
B-MDR HERZ D516V S315T1 A16G
S315T2
Ms1 Susceptible MANU Wild type Wild type Wild type
Ms2
Ms3
M-MDR HERZ D516V S315T1 A16G
S315T2
The table describes the strains selected for the study along with the genotypic mutations found using the Genotype MTBDR plus line probe assay.
Cs1, Cs2, Cs3 are CAS drug susceptible strains.
Bs1, Bs2 are Beijing drug susceptible strains.
Ms1, Ms2, Ms3 are MANU drug susceptible strains.
C-MDR, B-MDR, M-MDR are CAS, Beijing and MANU drug resistant strains respectively.
Wild type indicates presence of all the bands on the hybridization membrane.
HERZ stand for Isoniazid, Ethambutol, Rifampicin and Pyrazinamide respectively.
doi:10.1371/journal.pone.0033507.t001
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measured. The sample was preserved in MB 7H9 broth at an
O.D600=0.6 at 270uC. A 15% glycerol stock was used for cryo-
preservation. CFU were counted for the preserved vial. During
assays, strains were used from these preserved stocks defrosted and
inoculated for further use.
In vitro competition assay
The drug susceptible strains from a single lineage in
combination with drug resistant strains from the same or different
lineages were used for competition as follows: Ten ml of MB7H9
broth, supplemented with ADC, 0.5% glycerol, were inoculated
separately in two 20 ml roller tubes, with an aliquot of rifampicin-
susceptible and an aliquot of rifampicin resistant strains such that
the cell density in the tube was 10
5 CFU/ml. These controls
independently depicted that the rifampicin susceptible and
rifampicin resistant strains were not retarded in growth.
Simultaneously, equal amounts (,0.5610
5 CFUs/ml) were co-
inoculated into a new 20 ml roller tube containing 10 ml MB7H9
broth supplemented with ADC and 0.5% glycerol. The separately
inoculated cultures were serially diluted on days 0, 3, 7, 10 & 14
and plated in triplicate on petri dishes containing 25 ml of
Middlebrook 7H11(MB7H11) (BD,USA) medium supplemented
with OADC (Oleic Acid Dextrose and Catalase, Becton
Dickinson, USA). The mixed cultures were serially diluted and
plated in triplicate on petri dishes containing 25 ml of
MB7H11medium with and without 1 mg/ml of rifampicin.
Framework of Analysis
I. Calculation of Relative Fitness. For each competition
experiment the mean of three CFUs was used for the calculation of
relative competitive fitness. At all time points, the CFU counts on
rifampicin plates indicated the number of rifampicin resistant cells
in the mixed cultures. The number of susceptible cells was
calculated by subtracting the number of resistant cells from the
total cell numbers revealed by CFU counts of the plain plates
(MB7H11 without rifampicin).
The relative competitive fitness W of the drug resistant strains
compared to the drug susceptible strain was calculated using the
formula [6]
W~(ln(Rf7Ri))7(ln(Sf7Si)
Ri and Si denote resistant and susceptible cells at baseline (day0)
respectively.
Figure 1. Competitive Relative Fitness (CRF) of drug resistant strains. The relative fitness of drug resistant strains is evaluated in competition
with drug susceptible strains (fitness Index 1, represented as a line parallel to X-axis) from the 3 predominant lineages. Cs1, 2, 3 are CAS drug
susceptible strains; Bs1, 2 are Beijing drug susceptible strains; Ms1, 2, 3 are MANU drug susceptible strains; C-MDR, B-MDR, M-MDR are CAS, Beijing &
MANU drug resistant strains respectively. The values of relative fitness indices have been presented in Table 1.The values are represented as mean 6
SD of 3 independent experiments. (Figure 1A) represents the fitness index of H37RV in presence of the 3 drug resistant strains. (Figure 1B) represents
the fitness index of drug resistant strains in the presence of CAS drug susceptible strains. (Figure 1C) represents the fitness index of drug resistant
strains in the presence of Beijing drug susceptible strains. (Figure 1D) represents the fitness index of drug resistant strains in the presence of MANU
drug susceptible strains.
doi:10.1371/journal.pone.0033507.g001
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(day14) respectively.
Means of 3 replicate competition assays were determined.
The variance in between the means of samples was analyzed
using ANOVA. Difference between the means were analyzed by t-
test. The drug resistant strain was considered fit than the drug
susceptible strain if its fitness index was more than 1 (the fitness
index of drug susceptible strain).
II. Calculation of generation time. For both drug
susceptible and resistant strains the generation time (g) was
calculated using the following formula,
g~t7n
Where, t=total time; n=no of generations.
n~(log10Nt{log10N0)7log2
Nt=Number of viable cells at final time t; N0=Number of viable
cells at time 0.
Results
Fitness of CAS, Beijing and MANU drug resistant strains
In the presence of H37Rv (Figure 1). In comparison to the
standard laboratory strain H37Rv (susceptible to all first line anti-
TB drugs, Table 1), the drug resistant strains had a reduced
fitness. However we found an overall significant difference in the
fitness indices of the 3 drug resistant strains with Beijing (B-MDR)
being the fittest followed by CAS (C-MDR) and MANU (M-
MDR) respectively (ANOVA, F2,9=4.84, p=0.03).
In the presence of drug susceptible strains from lineages
(Figure 1 & Table 2). We observed an overall significant
difference in the fitness indices of the drug resistant strains (C-
MDR, B-MDR, M-MDR) in the presence of drug susceptible
strains from 3 different lineages (ANOVA, F2,6=29.98, p,0.05).
The inhibition was prominent in the presence of drug susceptible
strains belonging to the same lineage. The growth rate of MANU
Table 2. Fitness indices of drug resistant strains in the
presence of drug susceptible strains from the 3 predominant
strain lineages.
C-MDR B-MDR M-MDR
H37Rv 0.260.02 0.760.003 0.1360.05
Cs1 0.2660.18 1.2160.80 5.1561.44
Cs2 0.0060.00 0.6360.75 20.5160.06
Cs3 0.0060.00 1.9260.93 3.0261.57
Bs1 2.2461.53 1.4561.45 3.6063.30
Bs2 0.7061.08 1.0060.10 1.4061.75
Ms1 0.2160.09 0.5060.08 0.0060.00
Ms2 0.0060.03 0.0260.02 0.0060.00
Ms3 0.0860.01 0.4460.03 0.0060.00
The values represent fitness indices of drug resistant strain in the presence of
drug susceptible strains from the 3 predominant lineages. The data is
represented as a mean 6 SD derived from 3 independent experiments. The
values represent fitness index on day 14 and have been used to plot Figure 1.
Cs1, Cs2, Cs3 are CAS drug susceptible strains.
Bs1, Bs2 are Beijing drug susceptible strains.
Ms1, Ms2, Ms3 are MANU drug susceptible strains.
C-MDR, B-MDR, M-MDR are CAS, Beijing and MANU drug resistant strains
respectively.
doi:10.1371/journal.pone.0033507.t002
Table 3. Mean generation time of independent strains in
axenic culture.
Sr no Strain ID
Generation time (h)Mean ±
SD
1 H37Rv 50.866.2
2 Cs1 98.769.5
3 Cs2 125.561.3
4 Cs3 103.561.3
5B s 1 9 6 66.3
6 Bs2 80.463.7
7M s 1 5 0 62.9
8 Ms2 65.769.3
9 Ms3 77.367.7
10 C-MDR 121.2611.3
11 B-MDR 73.766
12 M-MDR 73.963.9
The values represent the generation time of all strains independently. The data
has been represented as mean 6 SD from 3 independent experiments and has
been used to plot Figure 2.
Cs1, Cs2, Cs3 are CAS drug susceptible strains;
Bs1, Bs2 are Beijing drug susceptible strains;
Ms1, Ms2, Ms3 are MANU drug susceptible strains;
C-MDR, B-MDR, M-MDR are CAS, Beijing and MANU drug resistant strains
respectively.
doi:10.1371/journal.pone.0033507.t003
Table 4. Generation time of strains in competition in axenic
media.
Generation Time (h) Mean ± SD
SusceptibleR H37Rv CAS Beijing MANU
ResistantQ
CAS (C-MDR) 29.262.3 82.2618.7 82.2611.2 100.4615.1
201.02±1.7 193.4±11.7 70.15±22.3 84.5±16.9
Beijing (B-MDR) 28.1+0.9 91.9+2.7 68.2+2.4 59.8+13.1
52.5±1.9 142.7±9.7 87.8±18.7 71.4±35.3
MANU(M-MDR) 29.860.6 50.9623.7 72.8649.9 39.768.2
373614.7 84.7610.6 121.8638.5 No growth
The italicized values are the median generation times of the drug susceptible
strains in the presence of the respective drug resistant strains. The values
formatted as bold are the mean generation times of the drug resistant strain in
the presence of the respective drug susceptible strain. The data has been
represented as mean 6 SD from 3 independent experiments. The values have
been used to plot Figure 3.
Generation time is calculated using the formula:
g~t7n
t=total time; n=no of generations.
n~(log10Nt{log10N0)7log2
Nt=Number of viable cells at final time t; N0=Number of viable cells at time 0.
doi:10.1371/journal.pone.0033507.t004
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(ANOVA, F2, 57=3.96, p,0.05) than drug susceptible strains of
the CAS and Beijing lineage when in competition with the drug
resistant strains of the same and different lineages.
The CAS drug resistant strains demonstrated a reduced fitness
index in the presence of drug susceptible strains from all 3 lineages.
No drug resistant strains from any of the 3 lineages were inhibited
in the presence of Beijing drug susceptible strain. In the presence
of the 2 drug susceptible MANU strains (Ms1 &Ms2) the growth
inhibition was observed only in the drug resistant M-MDR strain.
In contrast the competing combine of the third MANU drug
susceptible strain (Ms3) and M-MDR resulted in no growth of
either strain.
Generation time of strains in independent and
competition culture (Table 3, 4; Figure 2, 3)
There was a significant difference (p,0.043, t-test) in the
generation time of the strains belonging to different lineages. CAS
had the longest generation time amongst the 3 lineages.
Additionally, the doubling times of C-MDR & M-MDR strains
were greatly reduced in the presence of respective drug susceptible
strains. Though the difference in doubling times of the strains
independently and in competition was not statistically significant
(p=0.427, t-test) there was a uniform trend observed of drug
susceptible strains growing faster in competition and drug resistant
strains growing faster independently.
Discussion
Earlier studies have elucidated the putative advantage that drug
resistant strains possess due to the presence of certain non-
synonymous substitutions in the rpoB locus. Elsewhere, reports
have highlighted the fitness of drug resistant strains such as the
‘Beijing’ from epidemic regions which are most often single strain
outbreaks
9. However, what remains to be elucidated is the fitness
of drug resistant strains in the presence of drug susceptible strains,
from an endemic region characterized by high strain variability
and population diversity.
In addition to the strain type, fitness may be also be affected by
the drug resistant mutations (and the fitness cost associated with it)
andthe assaysystem (theculture mediaorthehost)whichinfluences
selection. In this study, usingthe GenotypeMTBDRplusline probe
assay,itwasidentifiedthatthemostcommonlyassociatedmutations
in the drug resistant strains, in the study population (Refer Materials
and Methods) were D516V (rpoB), S315T1/T2 (katG) and A16G
(inhA). The frequency of their occurrence was 42.1%, 74.1% and
76.5% respectively (unpublished data). Studies from North India
evaluating drug resistance mutation and MIC for rpoB have
documented a low level resistance associated with D516V (1–
Figure 2. Independent growth curves of drug susceptible and drug resistant strains. The growth curves measured by plating for CFU of
the drug resistant and susceptible strains in 7H9 broth over a period of 14 days have been plotted against time. The data is represented as mean 6
SD of 3 independent experiments. (Figure 1A) represents growth curves of drug susceptible and resistant strains of CAS lineage in single culture.
(Figure 1B) represents growth curves of drug susceptible and resistant strains of Beijing lineage in single culture. (Figure 1C) represents growth
curves of drug susceptible and resistant strains of MANU lineage in single culture. (Figure 1D) represents growth curve of H37Rv in single culture.
doi:10.1371/journal.pone.0033507.g002
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high fitness costs. Hence the observations in this study can be
imputed to factors other than the mutations.
The assay system (which has earlier been shown to alter the
measure of fitness of M.tb strains [17]) in this study was of non-
selective nutrient media (MB7H11), which is expected to
demonstrate the basic ‘‘wild-type’’ fitness of M.tb strains.
Therefore, H37Rv, a standard laboratory drug susceptible strain
(not exposed to selection through host and drug pressures), should
demonstrate the highest fitness. This was confirmed in the
observation of reduced fitness of all drug resistant strains in the
presence of H37Rv.
The decreased fitness of C-MDR (0–0.26) in the presence of
drug susceptible strains from the CAS lineage could be due to the
fact that CAS in itself is found to be a slow growing strain with a
generation time of (121.2611.3 h) (Table 3) which is significantly
higher than the drug resistant strains belonging to the Beijing and
MANU lineages (p,0.005, t test). It has been observed [20] that
the slow growing M.tb strains accumulate a single base pair
substitution in rpoB locus at the rate of 10
210. This could imply
that for a compensatory mutation to have established itself and
return the strain to its original fitness would take much longer.
Thus, it is likely that the mutation has associated a cost to fitness
which is as yet inadequately compensated.
In contrast, the enhanced fitness of Beijing drug resistant strain
(1.00–1.92) over drug susceptible strains of the CAS and Beijing
lineages could be due to specific compensatory mechanisms
present in the Beijing strains from this region which are
significantly associated with MDR [11,15]. It could also be due
to the fact that Beijing genotype is known to be associated with
several outbreaks across the world implying mechanisms which
permit its predominance even in the presence of other competing
strains. This highlights the virulent nature of the strain and its high
transmission efficiency across different continents and thus its
inherent ability to multiply faster in the presence of several strain
types. However in a TB endemic region like India, native strains
are strongly adapted to the population and thus may not allow
Beijing strains to multiply to an epidemic proportion. We also
project that given the ‘un-restricted’ nature of Beijing MDR
strains, a disproportionate increase of these, in an endemic setting
like ours could lead to an impending epidemic outbreak. Thus
surveillance systems for strain make up in vulnerable regions may
be required for timely warning of drug resistant epidemics
The MANU drug resistant strains show a high fitness index
(1.44–5.51) in the presence of CAS and Beijing drug susceptible
strains but do not grow in the presence of MANU drug susceptible
strains. A sympatry between MANU and the host may be
responsible for the predominance [14] of the strain in the region
Figure 3. Growth curves of drug susceptible and drug resistant strains in competition. The growth curves of drug resistant and
susceptible strains measured by plating for CFU in 7H9 broth in competition over a period of 14 days have been plotted against time. The data is
represented as mean 6SD of 3 independent experiments. (Figure 1A) represents the growth curves of drug susceptible strain of CAS lineage in
competition with the drug resistant strains of the CAS, Beijing and MANU lineage. (Figure 1B) represents the growth curves of drug susceptible strain
of Beijing lineage in competition with the drug resistant strains of the CAS, Beijing and MANU lineage. (Figure 1C) represents the growth curves of
drug susceptible strain of MANU lineage in competition with the drug resistant strains of the CAS, Beijing and MANU lineage.
doi:10.1371/journal.pone.0033507.g003
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other genotypes. The mutual inhibition of MANU drug resistant
and susceptible strains could be indicative of an interesting
phenomenon of cell-cell communication used by bacteria and
mediated through diffusible signal molecules to confine the
population density and to modulate their behavior in response
to the environment. An analogy was found in ‘deadly’ sibling
colonies of Paenebacillus dendritiformis mutually inhibiting each other
[21].
While the MANU drug susceptible strains and H37Rv grew
faster in competition (when compared to their independent growth
rate), the difference was greater in H37Rv as compared to the
MANU drug susceptible strains. Although this was not statistically
significant, it still indicates the fitness of the H37Rv (a laboratory
strain) in non-selective media, as compared to MANU (a drug
susceptible clinical strain) which is probably better adapted to the
selective host conditions.
Observations elsewhere indicate that even in the absence of
drug pressure, drug resistant strains with relatively low basic
reproductive number may nonetheless persist within co-infected
hosts providing opportunities for selection, but do not out compete
its relative successful competitor, the drug susceptible strains [22].
The findings from the present study are probably representative of
this scenario and also highlight the possibility that the slow
growing drug resistant strains may not be completely inhibited,
awaiting the opportunity of resuming more rapid growth and
changing the dynamics of competition.
Whilst the results demonstrate the association between non-
synonymous substitutions and strain fitness they also highlight that
it is the competing strain and its genotype that has a significant
bearing on the fitness of the strain rather than the mutation itself.
To explain this we choose the example of the MANU drug
resistant strain (M-MDR) which bears non synonymous substitu-
tions in both rpoB and inhA. If it is assumed that the substitutions
bore a fitness cost which was later compensated in the bacterium it
should have remained so under most in vitro conditions. However it
was seen that though MANU strains exhibited the highest fitness
index in the presence of drug susceptible CAS and Beijing strains
but they were strongly inhibited by MANU drug susceptible
strains.
It is most likely that the pathogen uses mechanisms other than
mutations to overcome the effects of drugs, such as differential
expression of genes [23], the production of bacteriocins [24] or
activation of drug efflux pumps. The cost of maintenance thereof,
is for the efflux pumps rather than for the mutation (which alters
the target site generating resistance) and the compensatory
mutation (which returns the original fitness).
We conclude that MANU drug susceptible strains are the fittest
while competing with the drug resistant isolates from the 3
predominant lineages of our cohort. Consequently, it may be
hypothesized, that being more fit; the predominant drug
susceptible strain in an endemic locale (like MANU in Mumbai)
may outgrow other strains in the region. This hypothesis bears
further testing.
Overall our findings strengthen the contention that in a given
geographical location, the fitness of a strain is influenced not only
by a particular non synonymous substitution but also by the
competing strains in the environment. The higher fitness index in
such competitive environment may also help predict the
predominance of a particular lineage in a given setting. Further
studies are needed to understand the mechanisms that drive the
interplay of inter and intra strain competition and also newer
methods to determine competition between drug susceptible
strains. Such methods may help elucidate the interplay of ‘nature’
and ‘nurture’ in prokaryotes.
Acknowledgments
The authors thank the field workers and patients for their support and
willingness to be a part of the study. The authors are also sincerely grateful
to the Mumbai District TB Control Society (MDTCS) of the Brihan-
mumbai Municipal Corporation (BMC), in particular Dr GT Ambe and
Dr A.Bamne for their co-operation and for allowing access to the patients
reporting to Revised National Tuberculosis Control Program (RNTCP).
Author Contributions
Conceived and designed the experiments: PB NM. Performed the
experiments: PB AC DD MT. Analyzed the data: PB NM. Contributed
reagents/materials/analysis tools: NM. Wrote the paper: PB NM.
References
1. Wagner A (2005) Robustness, evolvability, and neutrality. FEBS Letters 579:
1772–1778.
2. Dhar N, McKinney J-D (2007) Microbial phenotypic heterogeneity and
antibiotic tolerance. Curr opin Microb 10: 30–38.
3. Normark B-H, Normark S (2002) Evolution and spread of antibiotic resistance.
J Internal Med 252: 91–106.
4. Kremer K, van der Werf M-J, Au B-K-Y, Anh D-D, Kam K-M, et al. (2009)
Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis
Beijing strains. Emer Infect Dis 15(2): 335–339.
5. Hanekom M, Spuy van der G-D, Streicher E, Ndabambi S-L, McEvoy C-R-E,
et al. (2007) A recently evolved sublineage of the Mycobacterium tuberculosis Beijing
strain family is associated with an increased ability to spread and cause disease.
J Clin Microbiol 45: 2263–2266.
6. Gagneux S, Long C-D, Small P, Van T, Schoolnik G-K, et al. (2006) The
competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:
1944–1946.
7. Strauss O-J, Warren R- M, Jordaan A, Streicher E-M, Hanekom M, et al. (2008)
Spread of a low fitness drug resistant Mycobacterium tuberculosis strain in a setting of
high Human Immunodeficiency Virus prevalence. J Clin Microb 46(4):
1514–1516.
8. Andersson DI, Levin BR (1999) The biological cost of antibiotic resistance. Curr
Opin Microb 2(5): 489–493.
9. Groll A-V, Martin A, Stehr M, Singh M, Portaels F, et al. (2010) Fitness of
Mycobacterium tuberculosis Strains of the W-Beijing and Non-W-Beijing
genotype. PLoS One 5(4): e10191.
10. D’souza D, Mistry N-F, Vira T, Dholakia Y, Hoffner S-E, et al. (2009) High
levels of Multidrug Resistant Tuberculosis in new and treatment-failure patients
from the Revised National Tuberculosis Control Programme in an Urban
metropolis (Mumbai) in Western India. BMC Public Health 9: 211.
11. Rodrigues C, Shenai S, Sadani M, Thakkar P, Sodha A, et al. (2006) Multi drug-
resistant tuberculosis in Mumbai: it’s only getting worse. Int J Tuberc Lung Dis
10: 1421–1422.
12. Chowgule R-V, Deodhar L (1998) Pattern of Secondary acquired drug
resistance to antituberculosis drugs in Mumbai, India 1991–1995.
Indian J Chest Dis Allied Sciences 40: 23–31.
13. Mistry N-F, Iyer A-M, D’souza D-T, Taylor G-M, Young D-B, et al. (2002)
SpoligotypingofMycobacteriumtuberculosis isolatesfrom multiple-drug-resistant
tuberculosis patients from Bombay, India. J Clin Microb 40(7): 2677–2680.
14. Chatterjee A, D’Souza D, Vira T, Bamne A, Ambe G-T, et al. (2010) Strains of
Mycobacterium tuberculosis from western Maharashtra, India, exhibit a high
degree of diversity and strain-specific associations with drug resistance, cavitary
disease, and treatment failure. J Clin Microb 10: 3593–3599.
15. Kulkarni S, Sola C, Filliol I, Rastogi N, Kadival G (2005) Spoligotyping of
Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis
in Mumbai, India. Research in Microbiology 156(4): 588–596.
16. Cohen T, Colijn C, Murray M (2008) Modeling the effects of strain diversity and
mechanisms of strain competition on the potential performance of new
tuberculosis vaccines. Proc Natl Acad Sci USA 105(42): 16302–16307.
17. Mariam HD, Mengistu Y, Hoffner SE, Andersson DI (2004) Effect of rpoB
mutations conferring resistance on fitness of Mycobacterium tuberculosis.
Antimicrob Agents Chemo 48(4): 1289–94.
18. Albert H, Bwanga F, Mukkada S, Nyesiga B, Ademun P-J, et al. (2010) Rapid
screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.
BMC infect Dis 10: 41.
Mycobacterium tuberculosis Strain Fitness
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e3350719. Siddiqui N, Shamim M, Hussain S, Choudhary RK, Ahmed N, et al. (2002)
Molecular characterization of Multi-Drug resistant isolates if Mycobacterium
tuberculosis from patients in North India. AAC 46(2): 443–50.
20. Billington OJ, McHugh TD, Gillespie SH (1999) Physiological Cost of Rifampin
Resistance Induced In Vitro in Mycobacterium tuberculosis. Antimicrob Agents
Chemo 43(8): 1866–1869.
21. Be’er A, Zhang HP, Florin E-L, Payne S-M, Jacob EB (2008) Deadly
competition between sibling bacterial colonies. Proc Natl Acad Sci USA
106(2): 428–433.
22. Sergeev R, Colijin C, Cohen T (2011) Models to understand the population level
impact of mixed strain M.tuberculosis infections. J theoretical Biology 280:
88–100.
23. Tailleux L, Wadell SJ, Pelizzola M, Mortellaro A, Withers M, et al. (2008)
Probing host pathogen cross talk by transcriptional profiling of both
mycobacterium tuberculosis and infected human dendritic cells and Macro-
phages. PloS ONE 3(1): e1403.
24. Saito H, Tomioka H, Watanabe T, Yoneyama T (1983) Mycobacteriocins
produced by mycobacteria are tween hydrolyzing esterases. J Bacteriol 153(3):
1294–1300.
Mycobacterium tuberculosis Strain Fitness
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33507